Incidence and prevalence of idiopathic inflammatory myopathies in Thailand from the Ministry of Public Health data analysis.
Dermatomyositis
Epidemiology
Incidence
Polymyositis
Prevalence
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 Sep 2024
04 Sep 2024
Historique:
received:
01
03
2024
accepted:
29
08
2024
medline:
5
9
2024
pubmed:
5
9
2024
entrez:
4
9
2024
Statut:
epublish
Résumé
The epidemiology of idiopathic inflammatory myopathies (IIMs) varies by country. Investigating the epidemiological profile among Thai IIMs could help to inform public health policy, potentially leading to cost-reducing strategies. We aimed to assess the prevalence and incidence of IIM in the Thai population between 2017 and 2020. A descriptive epidemiological study was conducted on patients 18 or older, using data from the Information and Communication Technology Center, Ministry of Public Health, with a primary diagnosis of dermatopolymyositis, as indicated by the ICD-10 codes M33. The prevalence and incidence of IIMs were analyzed with their 95% confidence intervals (CIs) and then categorized by sex and region. In 2017, the IIM cases numbered 9,074 among 65,204,797 Thais, resulting in a prevalence of 13.9 per 100,000 population (95% CI 13.6-14.2). IIMs were slightly more prevalent among women than men (16.8 vs 10.9 per 100,000). Between 2018 and 2020, the incidence of IIMs slightly declined from 5.09 (95% CI 4.92-5.27) in 2017 and 4.92 (95% CI 4.76-5.10) in 2019 to 4.43 (95% CI 4.27-4.60) per 100,000 person-years in 2020. The peak age group was 50-69 years. Between 2018 and 2020, the majority of cases occurred in southern Thailand, with incidence rates of 7.60, 8.34, and 8.74 per 100,000 person-years. IIMs are uncommon among Thais, with a peak incidence in individuals between 60 and 69, especially in southern Thailand. The incidence of IIMs decreased between 2019 and 2020, most likely due to the COVID-19 pandemic, which reduced reports and investigations.
Identifiants
pubmed: 39232120
doi: 10.1038/s41598-024-71633-7
pii: 10.1038/s41598-024-71633-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20646Informations de copyright
© 2024. The Author(s).
Références
Ashton, C., Paramalingam, S., Stevenson, B., Brusch, A. & Needham, M. Idiopathic inflammatory myopathies: A review. Intern. Med. J. 51(6), 845–852 (2021).
doi: 10.1111/imj.15358
pubmed: 34155760
Hočevar, A. et al. Survival of patients with idiopathic inflammatory myopathies in Slovenia. Front. Med. 20(8), 801078 (2021).
doi: 10.3389/fmed.2021.801078
Essouma, M., Noubiap, J. J., Singwe-Ngandeu, M. & Hachulla, E. Epidemiology of idiopathic inflammatory myopathies in Africa: A contemporary systematic review. J. Clin. Rheumatol. Pract. Rep. Rheum. Musculoskelet. Dis. 28(2), e552–e562 (2022).
Furst, D. E., Amato, A. A., Iorga, ŞR., Gajria, K. & Fernandes, A. W. Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve. 45(5), 676–683 (2012).
doi: 10.1002/mus.23302
pubmed: 22499094
Smoyer-Tomic, K. E., Amato, A. A. & Fernandes, A. W. Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: An administrative claims analysis. BMC Musculoskelet. Disord. 15(13), 103 (2012).
doi: 10.1186/1471-2474-13-103
Rosa, J. et al. Incidence and prevalence of polymyositis and dermatomyositis in a health management organization in Buenos Aires. J. Clin. Rheumatol. Pract. Rep. Rheum. Musculoskelet. Dis. 19(6), 303–307 (2013).
Oddis, C. V., Conte, C. G., Steen, V. D. & Medsger, T. A. Incidence of polymyositis-dermatomyositis: A 20-year study of hospital diagnosed cases in Allegheny County, PA 1963–1982. J. Rheumatol. 17(10), 1329–1334 (1990).
pubmed: 2254890
Wilson, F. C., Ytterberg, S. R., St Sauver, J. L. & Reed, A. M. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. J. Rheumatol. 35(3), 445–447 (2008).
pubmed: 18203321
Bendewald, M. J., Wetter, D. A., Li, X. & Davis, M. D. P. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: A population-based study in Olmsted County, Minnesota. Arch. Dermatol. 146(1), 26–30 (2010).
doi: 10.1001/archdermatol.2009.328
pubmed: 20083689
Lynn, S. J., Sawyers, S. M., Moller, P. W., O’Donnell, J. L. & Chapman, P. T. Adult-onset inflammatory myopathy: North Canterbury experience 1989–2001. Intern. Med. J. 35(3), 170–173 (2005).
doi: 10.1111/j.1445-5994.2004.00764.x
pubmed: 15737137
Limaye, V. et al. The epidemiology of dermatomyositis in South Australia. APLAR J. Rheumatol. 10(2), 94–100 (2007).
doi: 10.1111/j.1479-8077.2007.00267.x
Tan, J. A. et al. Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: A 30-year epidemiologic study of histology-proven cases. Int. J. Rheum. Dis. 16(3), 331–338 (2013).
doi: 10.1111/j.1756-185X.2011.01669.x
pubmed: 23981756
Patrick, M., Buchbinder, R., Jolley, D., Dennett, X. & Buchanan, R. Incidence of inflammatory myopathies in Victoria, Australia, and evidence of spatial clustering. J. Rheumatol. 26(5), 1094–1100 (1999).
pubmed: 10332974
Koh, E. T. et al. Adult onset polymyositis/dermatomyositis: Clinical and laboratory features and treatment response in 75 patients. Ann. Rheum. Dis. 52(12), 857–861 (1993).
doi: 10.1136/ard.52.12.857
pubmed: 8311535
pmcid: 1005215
Benbassat, J., Geffel, D. & Zlotnick, A. Epidemiology of polymyositis-dermatomyositis in Israel, 1960–76. Isr. J. Med. Sci. 16(3), 197–200 (1980).
pubmed: 7390760
Prieto-Peña, D. et al. Epidemiological and genetic features of anti-3-hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review. Eur. J. Intern. Med. 101, 86–92 (2022).
doi: 10.1016/j.ejim.2022.04.017
pubmed: 35487805
Meyer, A. et al. Incidence and prevalence of inflammatory myopathies: A systematic review. Rheumatol. Oxf. Engl. 54(1), 50–63 (2015).
doi: 10.1093/rheumatology/keu289
Kaipiainen-Seppänen, O. & Aho, K. Incidence of rare systemic rheumatic and connective tissue diseases in Finland. J. Intern. Med. 240(2), 81–84 (1996).
doi: 10.1046/j.1365-2796.1996.14843000.x
pubmed: 8810933
Weitoft, T. Occurrence of polymyositis in the county of Gävleborg, Sweden. Scand. J. Rheumatol. 26(2), 104–106 (1997).
doi: 10.3109/03009749709115827
pubmed: 9137324
Aguilar-Vazquez, A. et al. Geographical latitude remains as an important factor for the prevalence of some myositis autoantibodies: A systematic review. Front. Immunol. 12, 672008 (2021).
doi: 10.3389/fimmu.2021.672008
pubmed: 33968081
pmcid: 8100663
Dobloug, C. et al. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; Data from a large and unselected Norwegian cohort. Ann. Rheum. Dis. 74(8), 1551–1556 (2015).
doi: 10.1136/annrheumdis-2013-205127
pubmed: 24695011
Dalakas, M. C. Polymyositis, dermatomyositis, and inclusion-body myositis. N. Engl. J. Med. 325(21), 1487–1498 (1991).
doi: 10.1056/NEJM199111213252107
pubmed: 1658649
Bernatsky, S. et al. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: Age, sex and regional differences. Ann. Rheum. Dis. 68(7), 1192–1196 (2009).
doi: 10.1136/ard.2008.093161
pubmed: 18713785
Dobloug, G. C. et al. High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study. Eur. J. Neurol. 22(4), 672-e41 (2015).
doi: 10.1111/ene.12627
pubmed: 25530508
Gazeley, D. J. & Cronin, M. E. Diagnosis and treatment of the idiopathic inflammatory myopathies. Ther. Adv. Musculoskelet. Dis. 3(6), 315–24 (2011).
doi: 10.1177/1759720X11415306
pubmed: 22870489
pmcid: 3383495
Anagnostopoulos, I. et al. The prevalence of rheumatic diseases in central Greece: A population survey. BMC Musculoskelet. Disord. 26(11), 98 (2010).
doi: 10.1186/1471-2474-11-98
Svensson, J., Arkema, E. V., Lundberg, I. E. & Holmqvist, M. Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: A nationwide population-based study. Rheumatol. Oxf. Engl. 56(5), 802–10 (2017).
doi: 10.1093/rheumatology/kew503
Yoshida, A. et al. Impaired physical function in patients with idiopathic inflammatory myopathies: Results from the multicentre COVAD patient-reported e-survey. Rheumatol. Oxf. Engl. 62(3), 1204–15 (2023).
doi: 10.1093/rheumatology/keac441
Chung, S. A. & Criswell, L. A. PTPN22: Its role in SLE and autoimmunity. Autoimmunity. 40(8), 582–90 (2007).
doi: 10.1080/08916930701510848
pubmed: 18075792
pmcid: 2875134
Tiniakou, E., Costenbader, K. H. & Kriegel, M. A. Sex-specific environmental influences on the development of autoimmune diseases. Clin. Immunol. Orlando Fla. 149(2), 182–91 (2013).
doi: 10.1016/j.clim.2013.02.011